Publication | Closed Access

C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition

Breast OncologyMedicineImmunologyImmune Checkpoint InhibitorBreast CancerStat3 InhibitionTriple-negative Breast CancerCancer TreatmentRadiation OncologyOncologyCell BiologyAnti-metastatic Effects